Challenges of vaccination and herd immunity in COVID-19 and management strategies
- PMID: 36172975
- PMCID: PMC9539035
- DOI: 10.1111/crj.13543
Challenges of vaccination and herd immunity in COVID-19 and management strategies
Abstract
Coronavirus disease 2019 (COVID-19), the highly contagious viral disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has spread worldwide with millions of cases and more than 5 million deaths to date. SARS-CoV-2 has caused serious damage all over the world with many countries experiencing the third or the fourth wave of the viral disease outbreaks, mainly due to the emergence of mutant variants. Those who unvaccinated remain most vulnerable to COVID-19 and its variants. COVID-19 vaccination, along with prevention strategies, is a critical measure to defense against the disease. COVID-19 vaccination can reduce the spread of virus and help protect susceptible population. Although herd immunity might not be realized solely by vaccination, COVID-19 vaccines have been proved to be effective in reducing the risk of severe disease, hospitalization, and even death. It is recommended that people get vaccinated as soon as they are eligible. This review summarizes the recent SARS-CoV-2 variants that brought challenges for vaccination and herd immunity and discusses promising management strategies.
Keywords: COVID-19; SARS-CoV-2; herd immunity; prevention; vaccination.
© 2022 The Authors. The Clinical Respiratory Journal published by John Wiley & Sons Ltd.
Conflict of interest statement
The authors report no conflicts of interest.
Similar articles
-
Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.Cells. 2021 Oct 29;10(11):2949. doi: 10.3390/cells10112949. Cells. 2021. PMID: 34831172 Free PMC article. Review.
-
The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.J Biol Regul Homeost Agents. 2021 Jan-Feb;35(1):1-4. doi: 10.23812/21-3-E. J Biol Regul Homeost Agents. 2021. PMID: 33377359
-
SARS-CoV-2 variants and COVID-19 vaccines: Current challenges and future strategies.Int Rev Immunol. 2023;42(6):393-414. doi: 10.1080/08830185.2022.2079642. Epub 2022 May 28. Int Rev Immunol. 2023. PMID: 35635216 Review.
-
SARS-CoV-2 elicits non-sterilizing immunity and evades vaccine-induced immunity: implications for future vaccination strategies.Eur J Epidemiol. 2023 Mar;38(3):237-242. doi: 10.1007/s10654-023-00965-x. Epub 2023 Feb 4. Eur J Epidemiol. 2023. PMID: 36738380 Free PMC article.
-
Impact of Microbiota: A Paradigm for Evolving Herd Immunity against Viral Diseases.Viruses. 2020 Oct 10;12(10):1150. doi: 10.3390/v12101150. Viruses. 2020. PMID: 33050511 Free PMC article. Review.
Cited by
-
Factors Associated to Community Practices Toward the COVID-19 Pandemic: A Cross-Sectional Study in Indonesia.J Multidiscip Healthc. 2024 Apr 29;17:1901-1912. doi: 10.2147/JMDH.S455396. eCollection 2024. J Multidiscip Healthc. 2024. PMID: 38706508 Free PMC article.
-
Artificial intelligence in drug resistance management.3 Biotech. 2025 May;15(5):126. doi: 10.1007/s13205-025-04282-w. Epub 2025 Apr 14. 3 Biotech. 2025. PMID: 40235844 Free PMC article. Review.
-
Mapping vulnerability for increased COVID-19 susceptibility and worse outcomes: a scoping review.Front Public Health. 2024 Oct 10;12:1432370. doi: 10.3389/fpubh.2024.1432370. eCollection 2024. Front Public Health. 2024. PMID: 39450391 Free PMC article.
-
Perception and practices on COVID-19 vaccination and booster dose acceptability among health-care workers - A questionnaire-based study.Perspect Clin Res. 2024 Jan-Mar;15(1):10-17. doi: 10.4103/picr.picr_64_23. Epub 2023 Oct 27. Perspect Clin Res. 2024. PMID: 38282629 Free PMC article.
-
Cognizance and mitigation of falsified immunization documentation: Analyzing the consequences for public health in Nigeria, with a focus on counterfeited COVID-19 vaccination cards: A case report.Health Sci Rep. 2024 Feb 25;7(2):e1885. doi: 10.1002/hsr2.1885. eCollection 2024 Feb. Health Sci Rep. 2024. PMID: 38410502 Free PMC article.
References
-
- WHO Coronavirus (COVID‐19) Dashboard. Accessed 29 Nov. 2021. https://covid19.who.int/
-
- WHO Coronavirus (COVID‐19) Dashboard. Accessed 29 Nov. 2021. https://covid19.who.int/table
-
- Cascella M, Rajnik M, Aleem A, et al. Features, evaluation, and treatment of coronavirus (COVID‐19). In: StatPearls. Treasure Island: StatPearls Publishing; 2021. Jan. - PubMed
Publication types
MeSH terms
Substances
Supplementary concepts
Grants and funding
- W2020-013/Construction of Multidisciplinary Cooperative Diagnosis and Treatment for Severe Pneumonia
- SHDC2020CR5010-002/Clinical Research Plan of SHDC
- 2020YFC2003700/National key R&D plan
- 20XD1401200/Science and Technology Commission of Shanghai Municipality
- 20Z11901000/Science and Technology Commission of Shanghai Municipality
- 20DZ2261200/Science and Technology Commission of Shanghai Municipality
- 8213000121/National Natural Science Foundation of China
- 82041003/National Natural Science Foundation of China
- 81800008/National Natural Science Foundation of China
- shslczdzk02201/Shanghai Municipal Key Clinical Specialty
- ZY(2021-2023)-0207-01/The Mechanisms of Antibiotic Resistance in Severe Pneumonia Treated with Traditional Chinese and Western Medicine
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous